Insider · CIK 0001266773

CALLICUTT JACK W

Reports to the SEC for 3 companies · NORCROSS, GA

sec.gov

Transactions

Companies

Filings

CIK

0001266773

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-16	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2026-01-16	GALTGALECTIN THERAPEUTICS INC · Restricted Stock UnitA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2026-01-06	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−20.4K sh	$3.67	−$74.7K	7,614
2026-01-05	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−25.7K sh	$3.90	−$100K	27,968
2026-01-02	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+60K sh	—	—	67,614
2026-01-02	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−13.9K sh	$4.20	−$58.4K	53,700
2026-01-01	GALTGALECTIN THERAPEUTICS INC · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−60K sh	—	—	0
2025-11-18	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+28.1K sh	$1.98	+$55.6K	35,714
2025-11-18	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+18.2K sh	$1.11	+$20.2K	25,824
2025-11-18	GALTGALECTIN THERAPEUTICS INC · Common stock (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−18.2K sh	—	—	0
2025-11-18	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−28.1K sh	$6.22	−$175K	7,614
2025-11-18	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−28.1K sh	—	—	0
2025-11-18	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−18.2K sh	$6.22	−$113K	7,614
2025-11-17	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+19.7K sh	$1.11	+$21.9K	27,315
2025-11-17	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−19.7K sh	$6.03	−$119K	7,614
2025-11-17	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+9,586 sh	$1.98	+$19K	17,200
2025-11-17	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−2,323 sh	$6.03	−$14K	7,614
2025-11-17	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−9,586 sh	$6.03	−$57.8K	7,614
2025-11-17	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,323 sh	$1.23	+$2,857.29	9,937
2025-11-17	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−9,586 sh	—	—	28,120
2025-11-17	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,323 sh	—	—	48,750
2025-11-17	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−19.7K sh	—	—	18,190
2025-11-10	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,880 sh	—	—	37,706
2025-11-10	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−1,675 sh	$6.03	−$10.1K	7,614
2025-11-10	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,736 sh	$1.23	+$2,135.28	9,350
2025-11-10	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,675 sh	$1.11	+$1,859.25	9,289
2025-11-10	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,675 sh	—	—	37,891
2025-11-10	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−1,880 sh	$6.02	−$11.3K	7,614
2025-11-10	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,736 sh	—	—	51,073
2025-11-10	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−1,736 sh	$6.03	−$10.5K	7,614
2025-11-10	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,880 sh	$1.98	+$3,722.4	9,694
2025-11-05	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+200 sh	$1.72	+$344	7,814
2025-11-05	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−200 sh	$6.00	−$1,200	7,614
2025-11-05	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−200 sh	—	—	39,586
2025-11-05	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−200 sh	$6.00	−$1,200	7,614
2025-11-05	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+200 sh	$1.11	+$222	7,814
2025-11-05	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−200 sh	$6.00	−$1,200	7,614
2025-11-05	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−200 sh	—	—	39,566
2025-11-05	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+200 sh	$1.98	+$396	7,814
2025-11-05	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−200 sh	—	—	52,809
2025-11-04	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10.7K sh	$1.72	+$18.5K	18,355
2025-11-04	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,914 sh	$1.98	+$17.6K	16,528
2025-11-04	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−10.7K sh	$6.07	−$65.2K	7,614
2025-11-04	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,974 sh	$1.11	+$9,961.14	16,588
2025-11-04	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10.7K sh	—	—	53,009
2025-11-04	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,914 sh	—	—	39,786
2025-11-04	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−8,974 sh	$6.07	−$54.5K	7,614
2025-11-04	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−8,914 sh	$6.07	−$54.1K	7,614
2025-11-04	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,974 sh	—	—	39,766
2025-11-03	GALTGALECTIN THERAPEUTICS INCS Sale	Chief Financial Officer	SSale	−1,250 sh	$6.01	−$7,512.5	7,614

Recent filings

Accepted (ET)
Jan 214
CALLICUTT JACK W0001133416-26-000030
SEC(opens sec.gov)
Jan 64
CALLICUTT JACK W0001133416-26-000006
SEC(opens sec.gov)
Nov 194
CALLICUTT JACK W0001133416-25-000057
SEC(opens sec.gov)

Companies

Address

C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240

NORCROSS, GA, 30071